Pharmacogenomic analyses identified variants of interest in CYP2D6, EPHX1, and SCN1A.<h4>Interpretation</h4>Precision medicine for drug-resistant epilepsy using mHealth and genetics may show use in a resource-limited setting. Here, CYP2D6 is linked to epilepsy.